CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 109 filers reported holding CYTEK BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,416 | -50.5% | 15,474 | -17.6% | 0.00% | -100.0% |
| Q1 2023 | $172,680 | -84.3% | 18,790 | -82.5% | 0.00% | -85.0% |
| Q4 2022 | $1,096,993 | +412.6% | 107,443 | +638.7% | 0.02% | +400.0% |
| Q3 2022 | $214,000 | -79.7% | 14,544 | -85.1% | 0.00% | -85.7% |
| Q1 2022 | $1,055,000 | -1.8% | 97,852 | +48.7% | 0.03% | -15.2% |
| Q4 2021 | $1,074,000 | +145.8% | 65,820 | +222.6% | 0.03% | +175.0% |
| Q3 2021 | $437,000 | – | 20,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $22,533,000 | 12.24% |
| Miura Global Management | 1,649,400 | $17,698,000 | 12.14% |
| RA Capital Management | 13,381,054 | $143,578,000 | 3.83% |
| HHLR ADVISORS, LTD. | 8,757,030 | $93,963,000 | 2.01% |
| PURA VIDA INVESTMENTS, LLC | 477,164 | $5,120,000 | 0.30% |
| RTW INVESTMENTS, LP | 916,838 | $9,838,000 | 0.25% |
| Glenview Capital Management | 500,000 | $5,365,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 73,743 | $791,000 | 0.12% |
| Parkwood LLC | 42,292 | $454,000 | 0.08% |
| Point72 Asset Management, L.P. | 1,536,079 | $16,482,000 | 0.07% |